Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK PM: Covid passports may not be possible until full vaccine rollout

Thu, 25th Mar 2021 15:03

(Alliance News) - UK Prime Minister Boris Johnson has said it may not be feasible to implement coronavirus health certificates until everyone has been offered a vaccine, as publicans criticised his plans.

The prime minister said on Thursday that the government will say more on their possible use in early April, and suggested they could also be based on whether individuals have developed antibodies through infection, as well as vaccinations and negative tests.

But landlords rejected their use after his earlier suggestion it could be up to them to decide whether to screen customers' certificates on entry, ahead of fresh details emerging of a possible incentive for pubs to adopt the measure.

Johnson also defended his credentials as a "freedom lover" as some lockdown-sceptic Conservative backbenchers prepared to rebel in a Commons vote to extend coronavirus laws for a further six months.

The boss of the Shepherd Neame chain said that making jabs mandatory for entry to pubs is a "fairly poorly thought-out idea", as trade bodies suggested the idea was "simply unworkable".

Johnson insisted "no decisions have been taken at all", saying that there will be an update on the review into their possible use on either April 5 or 12, and said that "whatever happens" the April 12 reopening of pub gardens will be unaffected.

The prime minister said that "I do think there is going to be a role for certification", though it is possible this will be limited to foreign travel.

"There are three basic components. There's the vaccine, there's your immunity you might have had after you've had Covid and there's testing – they are three things that could work together," Johnson told broadcasters during a visit to the Monkey Puzzle Day Nursery in Greenford.

But he acknowledged there are "moral complexities" and "ethical problems" that must be addressed, raising concerns that pregnant women and those with medical reasons cannot be vaccinated.

"You might only be able to implement a thoroughgoing vaccination passport scheme, even if you wanted such a thing, in the context of when absolutely everybody had been offered a vaccine," Johnson added.

Ministers have insisted that their target of offering all adults a vaccine by the end of July will be met despite the EU's threat to control supplies from the continent.

EU leaders will discuss proposals aimed at tightening restrictions on vaccine exports at a virtual European Council summit on Thursday.

Meanwhile, MPs will be asked to approve the regulations for the route out of lockdown and keep some of the emergency powers in the Coronavirus Act in place until September.

Though they are expected to pass comfortably because Labour will not oppose them, the leader of the Covid Recovery Group of lockdown-sceptic Tory MPs was highly critical of the move.

Mark Harper, a former chief whip, said he has not "heard a single good answer about why" the government wants to extend "very significant draconian powers" for a further six months.

Ahead of the vote, Johnson said: "The libertarian in me is also trying to protect people's fundamental right to life and their ability to live their lives normally.

"And the only way really to restore that for everybody is for us to beat the disease and the best path to freedom is down the cautious but irreversible road map that we've set out – that's what the freedom lover wants."

On Wednesday, the prime minister said it "may be up to individual publicans" whether they carry out health certificate checks on punters.

Jonathan Neame, the chief executive of Shepherd Neame pub group, ruled out making vaccines mandatory for entry to his premises, warning bar staff could be "subject to intimidation".

"This is fraught with difficulty, I think, and it is, in my view, a fairly poorly thought out idea at this stage," he told BBC Radio 4's Today programme.

Kate Nicholls, the chief executive of the UKHospitality trade body, said the plan is "simply unworkable" and the British Beer and Pub Association said the requirement would not be "appropriate or necessary".

Cabinet Office minister Michael Gove is reviewing the possible use of coronavirus status certificates under plans to ease England's lockdown.

The use of certificates may not be as straightforward as vaccine or no vaccine, as recent negative test status may also be considered.

A Whitehall source told the PA news agency that landlords may be able to scrap social distancing if they check Covid health certificates on entry, in a move that would allow them to operate at much higher capacity.

Under the suggestion being considered in the review, those who do not want to enforce the checks would be allowed to reopen but would have to ensure social distancing is maintained.

Johnson insisted "blockades" are not the way forward as EU leaders were holding a virtual meeting to discuss tightening vaccine export restrictions, as the bloc is embroiled in an enduring row over supply with AstraZeneca PLC.

A joint statement moving to cool tensions said the two sides were seeking a "win-win" deal to increase supplies across the UK and EU.

Government data up to Tuesday showed 28.7 million people have received a first vaccine dose, a rise of 325,650 on the previous day.

A further 98 people had died within 28 days of testing positive for Covid-19 as of Wednesday, bringing the total by that measure to 126,382.

As of 9am on Wednesday, there had been a further 5,605 lab-confirmed cases in the UK, bringing the total to 4.3 million.

By Sam Blewett

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.